Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Vericel Corp (NASDAQ:VCEL)

2.80
Delayed Data
As of May 27
 -0.02 / -0.71%
Today’s Change
1.69
Today|||52-Week Range
6.69
+8.53%
Year-to-Date
No recent news for Vericel Corp.

Today’s Trading

Previous close2.82
Today’s open2.84
Day’s range2.77 - 2.91
Volume178,984
Average volume (3 months)933,438
Market cap$68.2M
Dividend yield--
Data as of 4:00pm ET, 05/27/2016

Growth & Valuation

Earnings growth (last year)+56.50%
Earnings growth (this year)+18.56%
Earnings growth (next 5 years)+1.00%
Revenue growth (last year)+77.69%
P/E ratioNM
Price/Sales1.20
Price/Book--

Competitors

 Today’s
change
Today’s
% change
REPHRecro Pharma Inc-0.04-0.49%
ALIMAlimera Sciences Inc+0.02+1.31%
CERUCerulean Pharma Inc0.000.00%
APDNApplied DNA Sciences...+0.05+1.77%
Data as of 4:00pm ET, 05/27/2016

Financials

Next reporting dateAugust 10, 2016
EPS forecast (this quarter)-$0.18
Annual revenue (last year)$51.2M
Annual profit (last year)-$16.3M
Net profit margin-31.93%

Profile

Sector
Health Technology
Industry
Medical Specialties
President, Chief Executive Officer &
Director
Dominick C. Colangelo
Chief Operating Officer
Daniel R. Orlando
Corporate headquarters
Cambridge, Massachusetts

Forecasts

Partner Offers

Search for Jobs